Skip to content
Advertisement

FILE - In this Jan. 6, 2021, file photo, Dr. Cedric Waechter, left, administers the Pfizer-BioNTech COVID-19 vaccine to a resident of the Bois Fleuris nursing home in Strasbourg in eastern France. As France examines why its vaccination campaign has started so slowly, the answer lies partly in the red tape and the government’s decision to start with perhaps the toughest group to reach: the elderly in nursing homes. (AP Photo/Jean-Francois Badias, File)

FILE - In this Jan. 6, 2021, file photo, Dr. Cedric Waechter, left, administers the Pfizer-BioNTech COVID-19 vaccine to a resident of the Bois Fleuris nursing home in Strasbourg in eastern France. As France examines why its vaccination campaign has started so slowly, the answer lies partly in the red tape and the government’s decision to start with perhaps the toughest group to reach: the elderly in nursing homes. (AP Photo/Jean-Francois Badias, File)

Featured Photo Galleries